MERIDIAN BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2022 OPERATING RESULTS
CINCINNATI, Nov. 22, 2022 /PRNewswire/ — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2022. Fourth Quarter 2022 Highlights (Comparison to Fourth Quarter Fiscal 2021): Consolidated net revenues totaled $65.7 million, a decrease of 14% year-over-year Diagnostics segment net revenues increased 14% year-over-year to […]